Unknown × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Myeloid × Clear all MoTD
Phase 2 Unknown
400 enrolled
VICTORY
Phase 1 Unknown
18 enrolled
Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies
Unknown
340 enrolled
SPACE2
Unknown
150 enrolled
Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT
Phase 1/2 Unknown
20 enrolled
Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT
Phase 1/2 Unknown
20 enrolled
NK Cells in Cord Blood Transplantation
Phase 1 Unknown
13 enrolled
Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT
Phase 2 Unknown
80 enrolled
ProT4
Phase 2 Unknown
114 enrolled
MacHaploMud
Phase 3 Unknown
344 enrolled
CEREAL
Phase 1 Unknown
29 enrolled
GLIDE
Phase 1/2 Unknown
20 enrolled
A 5 Day Course of Fludarabine and Cytarabine Followed by Full Intensity Allogeneic Stem Cell Transplantation (FA5-Bucy) in Treating Patients With High-risk, Recurrent or Refractory Acute Leukemia and Advanced Myelodysplastic Syndrome
Unknown
50 enrolled
B-cell therapy
Phase 1/2 Unknown
15 enrolled
Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
Phase 2 Unknown
25 enrolled
Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders
Phase 2 Unknown
52 enrolled
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia
Phase NA Unknown
35 enrolled
Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer
Phase 1 Unknown
30 enrolled
Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
Phase 2 Unknown
30 enrolled
Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections
Phase 1 Unknown
20 enrolled
Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma
Phase 2 Unknown
60 enrolled
Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation
Phase 2 Unknown
80 enrolled
Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease
Phase NA Unknown
200 enrolled
Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer
Unknown
96 enrolled
Unrelated Double Umbilical Cord Blood Units Transplantation
Phase 2/3 Unknown
10 enrolled
HPDSC
Unknown
6 enrolled
Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia
Phase 2 Unknown
50 enrolled
Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain
Phase 3 Unknown
214 enrolled
Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome
Phase 3 Unknown
207 enrolled
Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor
Phase 2 Unknown
40 enrolled
Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation
Phase 2 Unknown
20 enrolled